These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7896455)
1. NM23 gene expression correlates with cell growth rate and S-phase. Caligo MA; Cipollini G; Fiore L; Calvo S; Basolo F; Collecchi P; Ciardiello F; Pepe S; Petrini M; Bevilacqua G Int J Cancer; 1995 Mar; 60(6):837-42. PubMed ID: 7896455 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the nm23.h1 gene inhibits cell proliferation. Cipollini G; Berti A; Fiore L; Rainaldi G; Basolo F; Merlo G; Bevilacqua G; Caligo MA Int J Cancer; 1997 Oct; 73(2):297-302. PubMed ID: 9335458 [TBL] [Abstract][Full Text] [Related]
3. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. Howlett AR; Petersen OW; Steeg PS; Bissell MJ J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158 [TBL] [Abstract][Full Text] [Related]
4. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878 [TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945 [TBL] [Abstract][Full Text] [Related]
6. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
7. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. Postel EH; Ferrone CA J Biol Chem; 1994 Mar; 269(12):8627-30. PubMed ID: 8132589 [TBL] [Abstract][Full Text] [Related]
9. Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3. Caligo MA; Cipollini G; Petrini M; Valentini P; Bevilacqua G Leuk Res; 1996 Feb; 20(2):161-7. PubMed ID: 8628015 [TBL] [Abstract][Full Text] [Related]
10. P53 is a regulator of the metastasis suppressor gene Nm23-H1. Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312 [TBL] [Abstract][Full Text] [Related]
11. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374 [TBL] [Abstract][Full Text] [Related]
13. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance. Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225 [TBL] [Abstract][Full Text] [Related]
14. Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation. Willems R; Van Bockstaele DR; Lardon F; Lenjou M; Nijs G; Snoeck HW; Berneman ZN; Slegers H J Biol Chem; 1998 May; 273(22):13663-8. PubMed ID: 9593706 [TBL] [Abstract][Full Text] [Related]
15. High levels of nm23 expression are related to cell proliferation in human prostate cancer. Igawa M; Rukstalis DB; Tanabe T; Chodak GW Cancer Res; 1994 Mar; 54(5):1313-8. PubMed ID: 8118821 [TBL] [Abstract][Full Text] [Related]
16. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Russell RL; Pedersen AN; Kantor J; Geisinger K; Long R; Zbieranski N; Townsend A; Shelton B; Brünner N; Kute TE Br J Cancer; 1998 Sep; 78(6):710-7. PubMed ID: 9743288 [TBL] [Abstract][Full Text] [Related]
17. Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes. Okada K; Urano T; Baba H; Furukawa K; Furukawa K; Shiku H Oncogene; 1996 Nov; 13(9):1937-43. PubMed ID: 8934540 [TBL] [Abstract][Full Text] [Related]
18. Identification of a second human nm23 gene, nm23-H2. Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104 [TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of nucleoside diphosphate kinase type B (nm23-H2) in cultured cells. Kraeft SK; Traincart F; Mesnildrey S; Bourdais J; Véron M; Chen LB Exp Cell Res; 1996 Aug; 227(1):63-9. PubMed ID: 8806452 [TBL] [Abstract][Full Text] [Related]
20. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]